Literature DB >> 15257512

Botulism: update and review.

Michael Cherington1.   

Abstract

Botulism is both an old and an emerging disease. Over 100 years ago, the classic food-borne type was found to be caused by ingesting contaminated food containing the toxin produced by a bacteria. In the first half of the 20th century a second form, wound botulism, was discovered. Three additional forms (infant, hidden, and inadvertent) were first described in the last quarter of the 20th century. Our understanding of how botulinum toxin blocks the release of acetylcholine at the neuromuscular junction has been clarified in the past 10 years. In the past 20 years, we have witnessed one of the strangest of all ironies in the history of medicine. The very lethal botulinum toxin is now being used as a treatment in an expanding list of disorders. Research is advancing in several directions. These new avenues include improved methods of preventing and treating botulism and additional novel uses of botulinum toxin as a therapeutic agent. In this article, the five clinical forms of botulism, the actions of botulinum toxins, electrodiagnostic methods, treatments, and possible future directions are discussed. Copyright 2004 Thieme Medical Publishers, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15257512     DOI: 10.1055/s-2004-830901

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  23 in total

1.  Neuromuscular junction border conflict.

Authors:  Gilles Naeije; Benjamin Legros; Diederik Zegers de Beyl
Journal:  J Neurol       Date:  2010-03-16       Impact factor: 4.849

Review 2.  Bioterrorism and the Role of the Clinical Microbiology Laboratory.

Authors:  Elizabeth Wagar
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

3.  Biosensor detection of botulinum toxoid A and staphylococcal enterotoxin B in food.

Authors:  Kim E Sapsford; Chris R Taitt; Nicole Loo; Frances S Ligler
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

Review 4.  The neurology of enteric disease.

Authors:  A J Wills; D S N A Pengiran Tengah; G K T Holmes
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-30       Impact factor: 10.154

Review 5.  From poison to remedy: the chequered history of botulinum toxin.

Authors:  F J Erbguth
Journal:  J Neural Transm (Vienna)       Date:  2007-04-26       Impact factor: 3.575

6.  Clinically and electrophysiologically diagnosed botulinum intoxication.

Authors:  Dilcan Kotan; Recep Aygul; Mustafa Ceylan; Yalcin Yilikoglu
Journal:  BMJ Case Rep       Date:  2013-01-03

7.  Longitudinal neurophysiological assessment of intramuscular type-A botulin toxin in healthy humans.

Authors:  L Lispi; L Leonardi; A Petrucci
Journal:  Neurol Sci       Date:  2017-11-11       Impact factor: 3.307

8.  Botulinum toxin and gastrointestinal tract disorders: panacea, placebo, or pathway to the future?

Authors:  Brian E Lacy; Kirsten Weiser; Abigail Kennedy
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-04

9.  SYBR green real-time PCR method to detect Clostridium botulinum type A.

Authors:  Lucia Fenicia; Fabrizio Anniballi; Dario De Medici; Elisabetta Delibato; Paolo Aureli
Journal:  Appl Environ Microbiol       Date:  2007-03-16       Impact factor: 4.792

10.  Wound botulism in injection drug users: time to antitoxin correlates with intensive care unit length of stay.

Authors:  Steven R Offerman; Melissa Schaefer; Joseph G Thundiyil; Matthew D Cook; James F Holmes
Journal:  West J Emerg Med       Date:  2009-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.